1-10 of 10
Katja Wosikowski
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract 3741: Antimetastatic activity of ISTH0047, a potent and selective TGF-beta 2 antisense oligonucleotide, in syngeneic lung metastatic model of mouse 4T1 mammary carcinoma

Free
Katja Wosikowski, Kathy Hasenbach, Jutta Petschenka, Diana Barea Roldan, Sebastian Kreiter, Ugur Sahin, Guillaume Serin, Julie-Orlane Redon, Marc Hillairet de Boisferon, Francis Bichat, Hanna Kohonen, Michel Janicot
Journal: Cancer Research
Cancer Res (2016) 76 (14_Supplement): 3741.
https://doi.org/10.1158/1538-7445.AM2016-3741
Published: 15 July 2016
View articletitled, Abstract 3741: Antimetastatic activity of ISTH0047, a potent and selective TGF-beta 2 antisense oligonucleotide, in syngeneic lung metastatic model of mouse 4T1 mammary carcinoma
Journal Articles

Abstract 716: ASPH_0047: a potent and selective antisense oligonucleotide-targeting transforming growth factor beta 2 (TGF-β2)

Free
Katja Wosikowski, Frank Jaschinski, Hanna Kohonen, Stephan Braun, Eugen Leo, Michel Janicot
Journal: Cancer Research
Cancer Res (2014) 74 (19_Supplement): 716.
https://doi.org/10.1158/1538-7445.AM2014-716
Published: 01 October 2014
View articletitled, Abstract 716: ASPH_0047: a potent and selective antisense oligonucleotide-targeting transforming growth factor beta 2 (TGF-β2)
Journal Articles

Abstract 717: Novel potent antisense oligonucleotides targeting transforming growth factor beta1 (TGF-β1)

Free
Frank Jaschinski, Hanna Korhonen, Stephan Braun, Katja Wosikowski, Michel Janicot
Journal: Cancer Research
Cancer Res (2014) 74 (19_Supplement): 717.
https://doi.org/10.1158/1538-7445.AM2014-717
Published: 01 October 2014
View articletitled, Abstract 717: Novel potent antisense oligonucleotides targeting transforming growth factor beta1 (TGF-β1)
Journal Articles

Abstract 3126: Renca RCC syngeneic model to evaluate efficacy of novel antisense oligonucleotides targeting TGF-β isoforms

Free
Hanna Korhonen, Julie-Orlane Redon, Damien France, Guillaume Serin, Francis Bichat, Frank Jaschinski, Katja Wosikowski, Michel Janicot
Journal: Cancer Research
Cancer Res (2014) 74 (19_Supplement): 3126.
https://doi.org/10.1158/1538-7445.AM2014-3126
Published: 01 October 2014
View articletitled, Abstract 3126: Renca RCC syngeneic model to evaluate efficacy of novel antisense oligonucleotides targeting TGF-β isoforms
Journal Articles

Synergistic interaction between the oral platinum analog satraplatin and erlotinib

Free
Auke Adema, Eveline Hoebe, Charlotte Huijts, Katja Wosikowski, Godefridus Peters
Journal: Cancer Research
Cancer Res (2007) 67 (9_Supplement): 5434.
Published: 01 May 2007
View articletitled, Synergistic interaction between the oral platinum analog satraplatin and erlotinib
Journal Articles

Synergistic in vitro anticancer activity of JM118, a metabolite of satraplatin, in combination with Herceptin

Free
Franz Obermayr, Marino Schuhmacher, Kurt Lobenwein, Christoph Schaab, Katja Wosikowski, Igor Ivanov
Journal: Cancer Research
Cancer Res (2006) 66 (8_Supplement): 319.
Published: 15 April 2006
View articletitled, Synergistic in vitro anticancer activity of JM118, a metabolite of satraplatin, in combination with Herceptin
Journal Articles

Evaluation of the efficacy of satraplatin (JM216) and its major metabolite JM118 in drug resistant cells and in combination with docetaxel

Free
Katja Wosikowski, Maureen G. Caligiuri, Faith Kaplan, Jimmy Xu, Nikolai Kley, Benno Rattel
Journal: Cancer Research
Cancer Res (2005) 65 (9_Supplement): 324.
Published: 01 May 2005
View articletitled, Evaluation of the efficacy of satraplatin (JM216) and its major metabolite JM118 in drug resistant cells and in combination with docetaxel
Journal Articles

Cytotoxic activity of satraplatin (JM216) and its metabolites in human prostate carcinoma cell lines

Free
Katja Wosikowski, Benno Rattel, Maureen Caligiuri, Gerhard Unteregger, Marcel Rozencweig
Journal: Cancer Research
Cancer Res (2004) 64 (7_Supplement): 1065.
Published: 01 April 2004
View articletitled, Cytotoxic activity of satraplatin (JM216) and its metabolites in human prostate carcinoma cell lines
Journal Articles

WK175, a Novel Antitumor Agent, Decreases the Intracellular Nicotinamide Adenine Dinucleotide Concentration and Induces the Apoptotic Cascade in Human Leukemia Cells

Available to Purchase
Katja Wosikowski, Karin Mattern, Isabel Schemainda, Max Hasmann, Benno Rattel, Roland Löser
Journal: Cancer Research
Cancer Res (2002) 62 (4): 1057–1062.
Published: 01 February 2002
View articletitled, WK175, a Novel Antitumor Agent, Decreases the Intracellular Nicotinamide Adenine Dinucleotide Concentration and Induces the Apoptotic Cascade in Human Leukemia Cells
Open the PDF for WK175, a Novel Antitumor Agent, Decreases the Intracellular Nicotinamide Adenine Dinucleotide Concentration and Induces the Apoptotic Cascade in Human Leukemia Cells in another window
Journal Articles

Brain-derived Neurotrophic Factor Protects Neuroblastoma Cells from Vinblastine Toxicity

Available to Purchase
Stefania Scala, Katja Wosikowski, Paraskevi Giannakakou, Paola Valle, June L. Biedler, Barbara A. Spengler, Enrico Lucarelli, Susan E. Bates, Carol J. Thiele
Journal: Cancer Research
Cancer Res (1996) 56 (16): 3737–3742.
Published: 01 August 1996
View articletitled, Brain-derived Neurotrophic Factor Protects Neuroblastoma Cells from Vinblastine Toxicity
Open the PDF for Brain-derived Neurotrophic Factor Protects Neuroblastoma Cells from Vinblastine Toxicity in another window